MalarVx is a bio-pharmaceutical company employing innovative new technologies to tackle development of a safe, affordable and effective malaria vaccine for around-world application. With the assembled MalarVx's team including veteran biotech and pharmaceutical start-up executives and scientists, seasoned international pharmaceutical executives, also involved are some of the world's top malaria researchers, and individuals with a broad base of experience in corporate finance and law as it pertains to the biopharmaceutical industry. The firm is structured to collaborate with various leading non-profits in malaria research aren and with other biopharmaceutical companies with complementary technologies. Other collbarators include the medical and research divisions in the US military along with relevant-field researchers in non-profit institutions, university infectious disease programs, various foundations committed to solving diseases of the third world as well as with for-profit pharmaceutical entities.
